[10] [11] This characteristic reduces the likelihood of traditional metabolic drug interactions
By activating additional receptors, dual and triple agonists can tap into a broader set of levers at once, offering the chance for greater weight reduction, improved glycemic control, and (possibly) fewer side effects compared to GLP-1 monotherapy
For example, semaglutide has suffered from limited supply in the US since 2022 due to its unprecedented demand, with these issues only recently being resolved [1]
Filsoof, a board-certified cardiologist and weight management expert, is a strong advocate for Night Shred GLP-1
Fluid timing : Distribute fluid intake throughout the day, with individualized recommendations regarding evening intake to balance hydration needs with potential nocturia